Savaria (TSE:SIS – Get Free Report) had its target price hoisted by stock analysts at Desjardins from C$27.00 to C$32.00 in a research note issued on Friday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Desjardins’ target price points to a potential upside of 23.31% from the company’s previous close.
Other research analysts have also recently issued reports about the company. Stifel Nicolaus upped their price target on Savaria from C$28.00 to C$29.00 and gave the stock a “buy” rating in a research note on Friday. TD Securities raised their target price on Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a report on Thursday. National Bank Financial lifted their target price on Savaria from C$26.00 to C$30.00 in a research report on Monday, December 22nd. Finally, Scotiabank increased their price target on shares of Savaria from C$25.00 to C$26.00 in a research report on Monday, November 10th. Seven analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of C$30.93.
View Our Latest Report on Savaria
Savaria Trading Down 1.7%
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported C$0.37 earnings per share for the quarter. Savaria had a net margin of 6.90% and a return on equity of 10.24%. The business had revenue of C$241.78 million during the quarter. As a group, equities analysts expect that Savaria will post 1.2048518 earnings per share for the current year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Read More
- Five stocks we like better than Savaria
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
